Related references
Note: Only part of the references are listed.Duration of immunity in recipients of two doses of 17DD yellow fever vaccine
VACCINE (2019)
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
Ana Carolina Campi-Azevedo et al.
EMERGING INFECTIOUS DISEASES (2019)
Single shot of 17D vaccine may not confer life-long protection against yellow fever
Pedro F. C. Vasconcelos
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2018)
Is a dose of 17D vaccine in the current context of Yellow Fever enough?
Cassia Fernanda Estofolete et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2018)
Yellow fever: a major threat to public health
The Lancet
LANCET (2018)
Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination
Christiane Costa-Pereira et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers
Nicole P. Lindsey et al.
JOURNAL OF TRAVEL MEDICINE (2018)
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies
Ana Carolina Campi-Azevedo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination
Michael Kongsgaard et al.
SCIENTIFIC REPORTS (2017)
Booster dose after 10 years is recommended following 17DD-YF primary vaccination
Ana Carolina Campi-Azevedo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Questions regarding the safety and duration of immunity following live yellow fever vaccination
Ian J. Amanna et al.
EXPERT REVIEW OF VACCINES (2016)
A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination
Rosanne W. Wieten et al.
PLOS ONE (2016)
Vaccination to gain humoral immune memory
Jana Sarkander et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Duration of post-vaccination immunity against yellow fever in adults
Iramaya Rodrigues Caldas et al.
VACCINE (2014)
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
Eduardo Gotuzzo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Yellow fever revaccination guidelines change - a decision too feverish?
M. P. Grobusch et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Yellow fever vaccination: Is one dose always enough?
Dipti Patel et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2013)
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies
Marisol Simoes et al.
BIOLOGICALS (2012)
17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children
Ana Carolina Campi-Azevedo et al.
PLOS ONE (2012)
Insights into human CD8+ T-cell memory using the yellow fever and smallpox vaccines
Rafi Ahmed et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody
Maria Luiza-Silva et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
Juliana Romualdo Nascimento Silva et al.
VACCINE (2011)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program
Luiz Antonio Bastos Camacho et al.
VACCINE (2007)
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
MJ Hepburn et al.
VACCINE (2006)
Functional analysis of human memory B-cell subpopulations:: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM
YH Shi et al.
CLINICAL IMMUNOLOGY (2003)
Share Paper
